Rapaflo Side Effects
Generic name: silodosin
Note: This document contains side effect information about silodosin. Some of the dosage forms listed on this page may not apply to the brand name Rapaflo.
Some side effects of Rapaflo may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to silodosin: oral capsule
Get emergency medical help if you have any of these signs of an allergic reaction while taking silodosin (the active ingredient contained in Rapaflo) hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using silodosin and call your doctor at once if you have a serious side effect such as:
-
feeling like you might pass out; or
-
penis erection that is painful or lasts 4 hours or longer.
Less serious side effects of silodosin may include:
-
mild dizziness;
-
headache;
-
diarrhea;
-
abnormal ejaculation; or
-
runny or stuffy nose, sore throat.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to silodosin: oral capsule
Genitourinary
Retrograde ejaculation was reversible upon discontinuation of silodosin (the active ingredient contained in Rapaflo)
Genitourinary side effects have included retrograde ejaculation (28.1%) and one case of priapism in U.S. clinical trials.
Nervous system
Nervous system side effects have included dizziness (3.2%), headache (2.4%), and insomnia (1% to 2%) in U.S. clinical trials.
Gastrointestinal
Gastrointestinal side effects have included diarrhea (2.6%) and abdominal pain (1% to 2%) in U.S. clinical trials.
Cardiovascular
Cardiovascular side effects have included orthostatic hypotension (2.6%) in U.S. clinical trials. One case of syncope occurred in a patient taking prazosin concomitantly with silodosin (the active ingredient contained in Rapaflo)
Respiratory
Respiratory side effects have included nasopharyngitis (2.4%), nasal congestion (2.1%), sinusitis (1% to 2%), and rhinorrhea (1% to 2%) in U.S. clinical trials.
Ocular
Ocular side effects including Intraoperative floppy iris syndrome (IRIS) have been observed in some patients undergoing phacoemulsification cataract surgery while being treated with alpha-1 blockers.
Most reports were in patients treated with an alpha-1 blocker at the time IFIS occurred, but in some instances the alpha-1 blocker had been stopped prior to surgery. The manufacturer recommends that patients be questioned to determine whether or not they have taken alpha-1 blockers prior to being considered for cataract surgery. If it is determined that the patient has taken an alpha-1 blocker, the patient's ophthalmologist should be prepared for possible modifications to their surgical technique that may be necessary should IFIS be observed during the procedure.
Other
Other side effects occurring in 1% to 2% of patients in clinical trials included asthenia and increased PSA levels.
Dermatologic
Dermatologic side effects reported postmarketing have included toxic skin eruption and purpura.
Hepatic
Hepatic side effects reported postmarketing have included jaundice and impaired hepatic function associated with increased transaminase values.
More Rapaflo resources
- Rapaflo Prescribing Information (FDA)
- Rapaflo Monograph (AHFS DI)
- Rapaflo Advanced Consumer (Micromedex) - Includes Dosage Information
- Rapaflo Consumer Overview
- Rapaflo MedFacts Consumer Leaflet (Wolters Kluwer)
- Silodosin Professional Patient Advice (Wolters Kluwer)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.




